301 related articles for article (PubMed ID: 31488084)
1. Ambulatory Toxicity Management (AToM) in patients receiving adjuvant or neo-adjuvant chemotherapy for early stage breast cancer - a pragmatic cluster randomized trial protocol.
Krzyzanowska MK; Julian JA; Powis M; Howell D; Earle CC; Enright KA; Mittmann N; Trudeau ME; Grunfeld E
BMC Cancer; 2019 Sep; 19(1):884. PubMed ID: 31488084
[TBL] [Abstract][Full Text] [Related]
2. Remote, proactive, telephone based management of toxicity in outpatients during adjuvant or neoadjuvant chemotherapy for early stage breast cancer: pragmatic, cluster randomised trial.
Krzyzanowska MK; Julian JA; Gu CS; Powis M; Li Q; Enright K; Howell D; Earle CC; Gandhi S; Rask S; Brezden-Masley C; Dent S; Hajra L; Freeman O; Spadafora S; Hamm C; Califaretti N; Trudeau M; Levine MN; Amir E; Bordeleau L; Chiarotto JA; Elser C; Husain J; Laferriere N; Rahim Y; Robinson AG; Vandenberg T; Grunfeld E
BMJ; 2021 Dec; 375():e066588. PubMed ID: 34880055
[TBL] [Abstract][Full Text] [Related]
3. Ambulatory Toxicity Management (AToM) Pilot: results of a pilot study of a pro-active, telephone-based intervention to improve toxicity management during chemotherapy for breast cancer.
Krzyzanowska MK; MacKay C; Han H; Eberg M; Gandhi S; Laferriere NB; Powis M; Howell D; Atzema CL; Chan KKW; Kukreti V; Mitchell S; Nayer M; Pasetka M; Knittel-Keren D; Redwood E
Pilot Feasibility Stud; 2019; 5():39. PubMed ID: 30891308
[TBL] [Abstract][Full Text] [Related]
4. Implementation of patient-reported outcomes for symptom management in oncology practice through the SIMPRO research consortium: a protocol for a pragmatic type II hybrid effectiveness-implementation multi-center cluster-randomized stepped wedge trial.
Hassett MJ; Wong S; Osarogiagbon RU; Bian J; Dizon DS; Jenkins HH; Uno H; Cronin C; Schrag D;
Trials; 2022 Jun; 23(1):506. PubMed ID: 35710449
[TBL] [Abstract][Full Text] [Related]
5. Study protocol of the Aerobic exercise and CogniTIVe functioning in women with breAsT cancEr (ACTIVATE) trial: a two-arm, two-centre randomized controlled trial.
Brunet J; Barrett-Bernstein M; Zadravec K; Taljaard M; LeVasseur N; Srikanthan A; Bland KA; Collins B; Kam JWY; Handy TC; Hayden S; Simmons C; Smith AM; Virji-Babul N; Campbell KL
BMC Cancer; 2020 Jul; 20(1):711. PubMed ID: 32736542
[TBL] [Abstract][Full Text] [Related]
6. Health-related quality of life in early breast cancer.
Groenvold M
Dan Med Bull; 2010 Sep; 57(9):B4184. PubMed ID: 20816024
[TBL] [Abstract][Full Text] [Related]
7. Patient-Reported Toxicities During Chemotherapy Regimens in Current Clinical Practice for Early Breast Cancer.
Nyrop KA; Deal AM; Shachar SS; Basch E; Reeve BB; Choi SK; Lee JT; Wood WA; Anders CK; Carey LA; Dees EC; Jolly TA; Reeder-Hayes KE; Kimmick GG; Karuturi MS; Reinbolt RE; Speca JC; Muss HB
Oncologist; 2019 Jun; 24(6):762-771. PubMed ID: 30552158
[TBL] [Abstract][Full Text] [Related]
8. Design of the Physical exercise during Adjuvant Chemotherapy Effectiveness Study (PACES): a randomized controlled trial to evaluate effectiveness and cost-effectiveness of physical exercise in improving physical fitness and reducing fatigue.
van Waart H; Stuiver MM; van Harten WH; Sonke GS; Aaronson NK
BMC Cancer; 2010 Dec; 10():673. PubMed ID: 21138561
[TBL] [Abstract][Full Text] [Related]
9. Population-based assessment of emergency room visits and hospitalizations among women receiving adjuvant chemotherapy for early breast cancer.
Enright K; Grunfeld E; Yun L; Moineddin R; Ghannam M; Dent S; Eisen A; Trudeau M; Kaizer L; Earle C; Krzyzanowska MK
J Oncol Pract; 2015 Mar; 11(2):126-32. PubMed ID: 25604597
[TBL] [Abstract][Full Text] [Related]
10. Does routine symptom screening with ESAS decrease ED visits in breast cancer patients undergoing adjuvant chemotherapy?
Barbera L; Sutradhar R; Howell D; Sussman J; Seow H; Dudgeon D; Atzema C; Earle C; Husain A; Liu Y; Krzyzanowska MK
Support Care Cancer; 2015 Oct; 23(10):3025-32. PubMed ID: 25711657
[TBL] [Abstract][Full Text] [Related]
11. Emergency department presentations in early stage breast cancer patients receiving adjuvant and neoadjuvant chemotherapy.
Tang M; Horsley P; Lewis CR
Intern Med J; 2018 May; 48(5):583-587. PubMed ID: 29722200
[TBL] [Abstract][Full Text] [Related]
12. The Transitions to Long-term In Home Ventilator Engagement Study (Transitions to LIVE): study protocol for a pragmatic randomized controlled trial.
Amin R; Gershon A; Buchanan F; Pizzuti R; Qazi A; Patel N; Pinto R; Moretti ME; Ambreen M; ; Rose L
Trials; 2022 Feb; 23(1):125. PubMed ID: 35130935
[TBL] [Abstract][Full Text] [Related]
13. Nursing intervention to enhance outpatient chemotherapy symptom management: Patient-reported outcomes of a randomized controlled trial.
Traeger L; McDonnell TM; McCarty CE; Greer JA; El-Jawahri A; Temel JS
Cancer; 2015 Nov; 121(21):3905-13. PubMed ID: 26194461
[TBL] [Abstract][Full Text] [Related]
14. The cost-effectiveness of a nurse-led care program for breast cancer patients undergoing outpatient-based chemotherapy - A feasibility trial.
Lai XB; Ching SSY; Wong FKY; Leung CWY; Lee LH; Wong JSY; Lo YF
Eur J Oncol Nurs; 2018 Oct; 36():16-25. PubMed ID: 30322505
[TBL] [Abstract][Full Text] [Related]
15. Feasibility and efficacy of a weight gain prevention intervention for breast cancer patients receiving neoadjuvant chemotherapy: a randomized controlled pilot study.
Basen-Engquist KM; Raber M; Carmack CL; Arun B; Brewster AM; Fingeret M; Schembre SM; Harrison C; Perkins HY; Li Y; Song J; Chen M; Murray JL
Support Care Cancer; 2020 Dec; 28(12):5821-5832. PubMed ID: 32249355
[TBL] [Abstract][Full Text] [Related]
16. A pragmatic randomized control trial and realist evaluation on the implementation and effectiveness of an internet application to support self-management among individuals seeking specialized mental health care: a study protocol.
Hensel JM; Shaw J; Jeffs L; Ivers NM; Desveaux L; Cohen A; Agarwal P; Wodchis WP; Tepper J; Larsen D; McGahan A; Cram P; Mukerji G; Mamdani M; Yang R; Wong I; Onabajo N; Jamieson T; Bhatia RS
BMC Psychiatry; 2016 Oct; 16(1):350. PubMed ID: 27756281
[TBL] [Abstract][Full Text] [Related]
17. Taxanes for the adjuvant treatment of early breast cancer: systematic review and economic evaluation.
Ward S; Simpson E; Davis S; Hind D; Rees A; Wilkinson A
Health Technol Assess; 2007 Oct; 11(40):1-144. PubMed ID: 17903394
[TBL] [Abstract][Full Text] [Related]
18. The eSMART study protocol: a randomised controlled trial to evaluate electronic symptom management using the advanced symptom management system (ASyMS) remote technology for patients with cancer.
Maguire R; Fox PA; McCann L; Miaskowski C; Kotronoulas G; Miller M; Furlong E; Ream E; Armes J; Patiraki E; Gaiger A; Berg GV; Flowerday A; Donnan P; McCrone P; Apostolidis K; Harris J; Katsaragakis S; Buick AR; Kearney N
BMJ Open; 2017 Jun; 7(5):e015016. PubMed ID: 28592577
[TBL] [Abstract][Full Text] [Related]
19. Feasibility randomised controlled trial of remote symptom chemotherapy toxicity monitoring using the Canadian adapted Advanced Symptom Management System (ASyMS-Can): a study protocol.
Moradian S; Krzyzanowska M; Maguire R; Kukreti V; Amir E; Morita PP; Liu G; Howell D
BMJ Open; 2020 Jun; 10(6):e035648. PubMed ID: 32554724
[TBL] [Abstract][Full Text] [Related]
20. A multi-center pragmatic, randomized, feasibility trial comparing standard of care schedules of filgrastim administration for primary febrile neutropenia prophylaxis in early-stage breast cancer.
Ibrahim MFK; Hilton J; Mazzarello S; Fergusson D; Hutton B; Robinson A; Califaretti N; Hsu T; Gertler S; Mates M; Stober C; Vandermeer L; Mallick R; Clemons M
Breast Cancer Res Treat; 2018 Apr; 168(2):371-379. PubMed ID: 29214415
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
